azithromycin

Changes in prevalence of Mycoplasma genitalium macrolide and fluoroquinolone resistance: notes from a 13-year retrospective survey in Dalarna County, Sweden
Suhella Tulsiani Drud, Carin Anagrius, Britta Loré, Karin Elfving, Jørgen Skov Jensen

Sexually Transmitted Infections Dec 2023, 99 (8) 507-512; DOI: 10.1136/sextrans-2023-055900
Prevalence of macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in metropolitan and overseas France
Sabine Pereyre, Cécile Laurier-Nadalié, Chloé Le Roy, Jennifer Guiraud, Amandine Dolzy, Nadege Hénin, Marie Gardette, Cécile Bébéar

Sexually Transmitted Infections Jun 2023, 99 (4) 254-260; DOI: 10.1136/sextrans-2022-055466
Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda
Francis Kakooza, Patrick Musinguzi, Meklit Workneh, Richard Walwema, Peter Kyambadde, Emmanuel Mande, Christopher Lubega, Jhamira M Nakasi, Reuben Kiggundu, Matthew M Hamill, Bernard S Bagaya, Mohammed Lamorde, Magnus Unemo, Yukari C Manabe

Sexually Transmitted Infections Jun 2021, 97 (4) 312-316; DOI: 10.1136/sextrans-2020-054581
Incident urogenital and anorectal Chlamydia trachomatis in women: the role of sexual exposure and autoinoculation: a multicentre observational study (FemCure)
Nicole H T M Dukers-Muijrers, Maarten Schim van der Loeff, Petra Wolffs, Sylvia M Bruisten, Hannelore M Götz, Titia Heijman, Helene Zondag, Mayk Lucchesi, Henry De Vries, Christian J P A Hoebe

Sexually Transmitted Infections Sep 2022, 98 (6) 427-437; DOI: 10.1136/sextrans-2021-055032
Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services
Michaela Joanne Day, Michelle Jayne Cole, Helen Fifer, Neil Woodford, Rachel Pitt

Sexually Transmitted Infections May 2022, 98 (3) 215-218; DOI: 10.1136/sextrans-2020-054897
S13.1 Does azithromycin have a future in the treatment of gonorrhoea and chlamydial infection?
Jane Hocking

Sexually Transmitted Infections Jul 2019, 95 (Suppl 1) A21-A22; DOI: 10.1136/sextrans-2019-sti.61
Choice of antibiotics for prophylaxis of bacterial STIs among individuals currently self-sourcing
Manik Kohli, David Reid, Caisey V Pulford, Alison Howarth, Jack Brown, Hamish Mohammed, Gwenda Hughes, Catherine H Mercer, John Saunders

Sexually Transmitted Infections Mar 2022, 98 (2) 158; DOI: 10.1136/sextrans-2021-055310
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial
Gillian Dean, Suneeta Soni, Rachel Pitt, Jonathan Ross, Caroline Sabin, Jennifer Whetham

Sexually Transmitted Infections May 2021, 97 (3) 177-182; DOI: 10.1136/sextrans-2020-054468
Lack of macrolide resistance in Mycoplasma genitalium infections in a cohort of pregnant women in South Africa
Remco P H Peters, Hyun-Sul Jung, Etienne E Muller, Marleen M Kock, Landon Myer, Jeffrey D Klausner, Dvora Joseph Davey

Sexually Transmitted Infections Dec 2021, 97 (8) 624-625; DOI: 10.1136/sextrans-2020-054583
Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa
Jolein G E Laumen, Lieke B van Alphen, Liteboho D Maduna, Charlotte M Hoffman, Jeffrey D Klausner, Andrew Medina-Marino, Marleen M Kock, Remco P H Peters

Sexually Transmitted Infections Mar 2021, 97 (2) 152-156; DOI: 10.1136/sextrans-2019-054371

Main menu

azithromycin

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

azithromycin

Pages